A signature-based classification of lung adenocarcinoma that stratifies tumor immunity

BACKGROUND: Immune-related subgroup classification in immune checkpoint blockade (ICB) therapy is largely inconclusive in lung adenocarcinoma (LUAD). MATERIALS AND METHODS: First, the single-sample Gene Set Enrichment Analysis (ssGSEA) and K-means algorithms were used to identify immune-based subtyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xun, Jiang, Dizhi, Li, Shunjia, Zhang, Xinyu, Zheng, Wendi, Cheng, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878554/
https://www.ncbi.nlm.nih.gov/pubmed/36713530
http://dx.doi.org/10.3389/fonc.2022.1023833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878554/
https://www.ncbi.nlm.nih.gov/pubmed/36713530
http://dx.doi.org/10.3389/fonc.2022.1023833

Ejemplares similares